These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8794983)

  • 1. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
    Anigbogu AN; Williams AC; Barry BW
    J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
    Saïd A; Makki S; Muret P; Humbert P; Millet J
    J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoemulsion containing 8-methoxypsoralen for topical treatment of dermatoses: Development, characterization and ex vivo permeation in porcine skin.
    Oliveira CA; Gouvêa MM; Antunes GR; Freitas ZMF; Marques FFC; Ricci-Junior E
    Int J Pharm; 2018 Aug; 547(1-2):1-9. PubMed ID: 29800737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study.
    Borowska K; Wołowiec S; Rubaj A; Głowniak K; Sieniawska E; Radej S
    Int J Pharm; 2012 Apr; 426(1-2):280-283. PubMed ID: 22310461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
    Schempp CM; Schöpf E; Simon JC
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin permeation of 5-methoxypsoralen from topical dosage forms.
    Colombo G; Artusi M; Santi P; Colombo P; Bettini R; Zucchi A; Nicoli S
    Drug Dev Ind Pharm; 2003 Feb; 29(2):247-51. PubMed ID: 12648022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Penetration kinetics of xanthotoxin across human skin and stratum corneum].
    Wang LY; Jöelle M; Huang FF; Yang DP
    Yao Xue Xue Bao; 2006 Sep; 41(9):878-81. PubMed ID: 17111837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE; Schregenberger N; Dummer R; Panizzon RG
    Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application.
    Colombo G; Zucchi A; Allegra F; Colombo P; Zani F; Santi P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(2):130-6. PubMed ID: 12637789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
    Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
    Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
    Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of buprenorphine through cadaver skin.
    Roy SD; Roos E; Sharma K
    J Pharm Sci; 1994 Feb; 83(2):126-30. PubMed ID: 8169777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy.
    Shephard SE; Langguth P; Panizzon RG
    Photodermatol Photoimmunol Photomed; 2001 Feb; 17(1):11-21. PubMed ID: 11169171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
    Asawanonda P; Amornpinyokeit N; Nimnuan C
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.